Renewable Energy Government Incentive Programs

Bharatbook added a new report on “Renewable Energy Government Incentive Programs” which gives continued investment and growth in the renewable energy sector.
Renewable Energy Government Incentive Programs report ( http://www.bharatbook.com/detail.asp?id=132176&rt=Renewable-Energy-Government-Incentive-Programs.html ) examines the current federal and state renewable energy incentive programs designed to encourage continued investment and growth in the renewable energy sector. The report is organized by state.

Federal and state governments are offering a myriad of renewable energy incentive programs, devised to encourage industry growth and energy savings through government-funded consumer and commercial initiatives, including tax rebate programs, and grants.

In recent years, renewable energy has become an important part of the United States’ government’s agenda. For instance, the Federal Energy Policy Act of 2005 (EPACT) established a tax deduction for energy-efficient commercial buildings applicable to qualifying systems and buildings.

More recently, the American Recovery and Reinvestment Act of 2009 extended many tax incentives originally introduced in EPACT and amended in the Emergency Economic Stabilization Act of 2008.

In 2008, total renewable energy consumption in the U.S. was 7315711 billion Btu, an over 7.5% increase from the year before. Hydroelectric power accounted for 33.5 percent of total renewable energy consumption. And biomass accounted for 53.25 percent. The remaining consumption is split between wind (7%), geothermal (5%), and solar (1.25%).

According to the EIA, the outlook for the next two decades is for continued U.S. reliance on fossil fuels, with coal growing faster than liquid fuels and natural gas. Modest growth in hydroelectric power and nuclear electric power is anticipated, as is a doubling of nonhydroelectric renewable energy by 2030.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=132176&rt=Renewable-Energy-Government-Incentive-Programs.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline

Whats Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline report ( http://www.bharatbook.com/detail.asp?id=131989&rt=Whats-Next-in-Vaccines-HIV-Malaria-Rabies-MRSA-and-30-Other-Vaccine-Targets-in-the-2010-2020-Pipeline.html ) examines and estimates the market for vaccines that have yet to be launched, including the following target areas : Addiction, Allergy, Alzheimer’s Disease, Anthrax, Asthma,Campylobacter Infection, Chlamydia, Croup, Dengue Fever, Diabetes, Ebola, Epstein-Barr Virus, Enterotoxigenic Escherichia coli,Helicobacter Pylori, Hepatitis, Herpesvirus, Hookworm, Hypertension, HIV/AIDS, Leishmaniasis, Malaria, MRSA Infection, Multiple Sclerosis, Obesity, Parainfluenza Virus Type 3, Parkinson’s Disease, Plague, Respiratory Syncytial Virus, Ross River Virus, Shigellosis, Smoking, Stroke,
Tuberculosis, West Nile Virus

The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many pharmaceutical companies are working on new prophylactics, some of which may see near-term marketing. What illnesses may see a vaccine option in the coming years? Which vaccines will have the most successful business model? Who are the major companies in this market, and possible new entrants? What can current vaccine success stories tell us about the future of the vaccine market?

Some of these vaccines may see success; some could be the blockbusters of the future. For marketers and industry watchers a knowledge of all of the potential vaccines will be important to understand how pharma is seeking to renew bottom line with aggressive prophylactic strategies, and who the winners and losers in the near future may be. Alison Sahoo has looked at the vaccine market three times in as many years and in this report applies a knowledge of what companies have done in the past to potential efforts.

There are a number of trends that will impact the industry that market watchers will want to know about, these trends; including: New Vaccine Technologies, DNA Vaccination, Innovative Delivery Systems, Edible Vaccines, Vaccine Patches, Funding Shortfalls. The report also discusses vaccine manufacturing methods and the approval process. In addition, the report focuses on the emerging vaccine activities of the following companies

Acambis plc, ACE BioSciences, AFFiRiS, ALK-Abello A/S, Allergy Therapeutics, Bavarian Nordic A/S, Baxter Healthcare, Celldex Therapeutics, Crucell, Cytos Biotechnology Financial GlaxoSmithKline, Hawaii Biotech, Intercell, Medimmune, Merck & Co. Inc, Mymetics, Nabi Biopharmaceuticals, Novartis, Opexa Therapeutics, Paladin Labs, Sanofi Pasteur

This report provides forecasted revenues for products in development out to 2020. The report does not cover indication expansions of existing vaccine products, nor does it cover vaccines for which products currently exist and are widely available, but may need improvement. Development of vaccines that incorporate new production methods (such as the migration of chicken eggs to mammal, yeast or other cells) is also excluded. Cancer vaccines are excluded an entire report on this topic. Sales estimates for each market segment represent global revenues and are expressed in current dollars. Information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=131989&rt=Whats-Next-in-Vaccines-HIV-Malaria-Rabies-MRSA-and-30-Other-Vaccine-Targets-in-the-2010-2020-Pipeline.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

Global Cardiovascular Devices Market 2008-2012

Bharatbook.com added a new report on “Global Cardiovascular Devices Market 2008-2012″ which gives the Global Cardiovascular Devices market and profiles the key vendors of this industry.
Global Cardiovascular Devices Market 2008-2012 report ( http://www.bharatbook.com/detail.asp?id=129839&rt=Global-Cardiovascular-Devices-Market-2008-2012.html ) represent one of the major markets in the medical equipment industry. This market consists of Cardiac Rhythm Management (CRM) devices, Interventional Cardiology (IC) devices, cardiovascular prosthetic devices, and cardiovascular surgery.

With the advancement in technology, better therapies and solutions have been introduced into the healthcare market. Further, due to the intense competition, the players are driven to introduce new cardiovascular devices. Also, the manufacturers are emphasizing in next generation cardiovascular devices; with improved design, deliverability, and conformability. The development of next generation heart valves and drug eluting coronary stents, along with significant practices of biocompatible and bioabsorbable materials is expected to continue to drive innovation within the market.

The ageing population, life saving benefits of cardiovascular devices, increasing patient base undergoing cardiac procedures, and growing health awareness are the key factors driving the growth of cardiovascular devices. Also, with the advancement in new innovative technologies, the companies are coming up with next generation devices, involving minimally invasive methods. Further, the significant practices of biocompatible and bioabsorbable materials in the cardiovascular devices will continue to drive innovation within the market.

The report forecasts the market size of the Global Cardiovascular Devices market for 2008-2012. Further, the report discusses about the segmentation of the Global Cardiovascular Devices market into various geographic regions. It also identifies the major market trends, drivers, and challenges existing for the Global Cardiovascular Devices market and profiles the key vendors of this industry.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=129839&rt=Global-Cardiovascular-Devices-Market-2008-2012.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

Drug Discovery In India and China – Gaining Momentum with Increasing Pressure on Cost Cutting

Bharatbook added a new report on “Drug Discovery In India and China – Gaining Momentum with Increasing Pressure on Cost Cutting” gives Future ffor the Drug Discovery Players in India and China.

Drug Discovery In India and China – Gaining Momentum with Increasing Pressure on Cost Cutting report ( http://www.bharatbook.com/detail.asp?id=130313&rt=Drug-Discovery-in-India-and-China-Gaining-Momentum-with-Increasing-Pressure-on-Cost-Cutting.html ) provides key data, information and analysis of the major trends and issues affecting the Drug Discovery market in India and China. The report provides a comprehensive insight into the drug discovery process and the key services that form a part of drug discovery process. The report also provides a detailed analysis Indian and Chinese drug market in terms of its size, share in the global drug discovery market, major service offering of the companies in India and China along with the major therapeutic areas of focus under those services. The report also talks about the factors that are driving the drug discovery market in India and China. The report delves into the key regulations, especially with respect to intellectual property rights protection in the two countries and how the regulations have benefited the drug discovery companies in these two nations. It also provides an insight into the government support initiatives in these countries to encourage the drug discovery research. The report also analyses key partnerships between the western pharma and the local companies in the two countries and the key trends emerging out of such partnerships. At the end, the report looks into the major challenges in the future that can restrict the growth of the drug discovery market in India and China.

Rising Financial and Regulatory Pressures on Western Pharma will Continue to Drive the Drug Discovery Research Market Growth in India and China
The pharmaceutical industries in the US and Europe are facing severe financial constraints which are expected to worsen in the years ahead. The pharma companies are under increasing pressure to reduce expenditure due to, the increasing cost of introducing a NME (New Molecular Entities) (more than $3 billion in 2008), tightening FDA regulatory issues, blockbuster drugs worth more than $100 billion set to expire by 2014 and drying pipelines These pressures are expected to drive the companies towards low-cost countries such as India and China to perform their R&D activities, one of their major expenses.
Over the last decade, India and China have developed significant capabilities in drug discovery research along with considerable capabilities in phase I & II clinical trials. Both countries are able to provide significant cost savings in the range of 60–70% for discovery research and clinical trials. With discovery research occupying close to one-third of the R&D expenditure for the Western pharmaceutical industry, outsourcing to low-cost countries is logical.

Inflammatory Diseases, Metabolic Disorders and Oncology are the Three Major Therapeutic Areas of Drug Discovery Research in India and China
While the Indian and Chinese drug discovery companies have developed major service capabilities, many of the companies have also defined their therapeutic research focus. Analysis of 12 Indian and 10 Chinese companies research portfolios reveal that inflammatory diseases (18 companies), metabolic disorders (18) and cancer (16) are the top three therapeutic areas Other major therapy areas include anti-infectives and CNS (Central Nervous System). Major inflammatory disease research includes; COPD (- Chronic Obstructive Pulmonary Disease), RA (Rheumatoid Arthritis), psoriasis, osteoarthritis, ulcerative colitis and atherosclerosis.
However, at the country level the therapeutic focus is found to be different. Indian companies have concentrated their efforts on metabolic disorders; primarily diabetes, obesity and dyslipidemia. Chinese companies have focused on oncology; primarily leukemia, cervical cancer, breast cancer and prostrate cancer.

Deals Landscape is Equally Driven by Mid-Size Pharma and Big Pharma with Oncology and Metabolic Disorders as Key Therapy Area of Focus
With improvements in the capabilities of Indian and Chinese companies, the intensity of discovery research collaborations with Western pharmaceutical companies has increased.. The deals market has been equally driven by big pharma as well as mid-size pharma. Over the past year, 41 major deals have taken place in India and China, of which 20 deals involved mid-size companies while 19 involved big pharma; mainly Merck, AstraZeneca, Johnson & Johnson and Pfizer. Two of the deals were with universities. However, the increasing interest of the mid-size pharmaceutical companies suggests the rising interest of such companies to exploit the cost and quality capabilities of India and China.

Many of these deals were focused on services rather than a therapeutic area. However, among those that had a therapeutic focus; oncology, metabolic disorders, infectious diseases and inflammatory diseases were the major therapies targeted.

Funding Problems and Talent Shortage Will Be the Two Biggest Challenges in Future for the Drug Discovery Players in India and China
While the drug discovery market in India and China is growing rapidly, its future growth faces two major challenges; funding problems, especially for the private companies, and significant talent shortages in biology and chemistry services. While China has considerable government support, a large part of the money goes to government funded research institutions and universities. In India, the government has adopted PPP model as a tool to encourage pharmaceutical innovation but the major beneficiaries include CSIR (Council of Scientific and Industrial Research) affiliated institutes and small pharmaceutical companies. Venture capitalists, in both the countries, are largely risk-averse to invest in early stage R&D activities.
Besides funding problems, the lack of a sufficient talent pool with the specialized skills, experience and employability will create further problems for the drug discovery companies in both the countries.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=130313&rt=Drug-Discovery-in-India-and-China-Gaining-Momentum-with-Increasing-Pressure-on-Cost-Cutting.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

Mobile Applications – Impacts on Network Operations and Wireless Business Opportunities

Bharatbook added a new report on “Mobile Applications: Impacts on Network Operations and Wireless Business Opportunities” which gives the In-depth analysis on Mobile applications.

Mobile Applications Impacts on Network Operations and Wireless Business Opportunities report ( http://www.bharatbook.com/detail.asp?id=130297&rt=Mobile-Applications-Impacts-on-Network-Operations-and-Wireless-Business-Opportunities.html ) focuses on the smart phone’s mobile applications impact in the wireless marketplace, especially with respect to network operations and business opportunities. Due to the rapid growth and evolution of the smart phone market, there are many conflicting developments now occurring. There are over 130 smart phone models currently on the market. The marketplace has developed quickly and there are only a few models that are popular and we will focus only on these units. This publication evaluates these particular smart phones and their impact on the wireless marketplace.

Key Findings:

* The Mobile application market forecast is a $9.0 billion revenue opportunity over the next few years.
* As the network operators desired, customers acquired smartphones and wireless data applications to improve their productivity.
* Due to the popularity of the Apple iPhone, the network operators supporting the iPhone are experiencing traffic congestion and throughput problems in areas with high concentrations of iPhone users.
* The handset vendors have taken the leadership role away from the network operators and are currently driving this market.
* Apple has defined and driven this market to its current state. All other players in this market are reacting to Apple and playing catch up.
* Statistics show smart phones generate 30 times the traffic of basic cell phones leading to the network congestion being experienced.

Questions Answered

* What is behind the network congestion on ATT network?
* Why did this happen?
* Can it be corrected?
* Where will this market go?

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=130297&rt=Mobile-Applications-Impacts-on-Network-Operations-and-Wireless-Business-Opportunities.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

Stem Cell Research – An integral part of therapeutics

Bharatbook added a new report on “Stem Cell Research – Market Trends, Investment Trends and Pipeline Analysis” which gives the key geographies and the role of Stem Cell Research.

Stem Cell Research – Market Trends, Investment Trends and Pipeline Analysis report ( http://www.bharatbook.com/detail.asp?id=130308&rt=Stem-Cell-Research-Market-Trends-Investment-Trends-and-Pipeline-Analysis.html ) revealed that High Unmet Needs Associated with Chronic Diseases Boosts Stem Cell Research and Development. Stem cell therapies are expected to serve the unmet needs that are associated with treatment of certain chronic diseases. In spite of advancements in medical technology, there are very few treatment options available in the market to cure certain cardiovascular disorders, cancers, autoimmune and inflammatory disorders, spinal cord injury and others. Also, most of these therapies treat the symptoms without curing the disease. Stem cell therapies have the capacity to fill this gap of unmet need through its novel therapeutic approach that has the ability to cure the diseases.

High Market Potential for Stem Cell Therapies has resulted in Establishing Strategic Partnerships between Large Pharmaceutical Companies and Stem Cell Research Based Companies
Strategic partnerships between Pharmaceutical companies and Stem cell research companies have given a boost to stem cell research and development. Almost 90% of the drugs in clinical trials fail due to factors such as lack of effectiveness and adverse side effects of the drug. Usually animal or tumor cells are being used and this leads to jury-rigged tests. Hence, all major pharmaceutical companies look forward to new technologies that would increase the possibility to launch new therapies in the market place. At present, there has been a spur in investments from pharmaceutical companies into stem cell research through strategic partnerships with stem cell research companies. Major pharmaceutical companies have planned and aligned their objectives to enter the stem cell market in the next five years. Pharmaceutical companies are also keen to explore various methods where stem cells could be utilized in the drug discovery process that would accelerate the discovery of novel drug molecules.

Promising Pipeline in Phase II and Phase III has Increased the Hopes of Commercialization of Stem Cell Therapies
The total number of stem cell clinical trials has increased tremendously over the last few years. The number of Phase II clinical trials has witnessed more than a 40% jump between 2005 and 2008. With more than five ongoing Phase III trials, the market is keenly awaiting the launch of these therapies within the next five years. The Preclinical research and Phase I trials have also increased at a phenomenal rate. This increase demonstrates the emerging interests in stem cell research across the globe.

Supportive Regulatory Environment Coupled with Increase in Investments have Bolstered the Growth of Stem Cell Research
In the United States, President Barack Obama has lifted the federal funding restrictions on embryonic stem cell research. With the removal of this barrier, the authority of the department of health and human services, including the National Institutes of Health (NIH) will encourage support for human embryonic stem cell research. This will enable new therapies and new discoveries and will potentially lead to dramatic advances in the understanding and treatment of conditions such as diabetes, heart diseases and Alzheimer’s. The federal funding and VC funding for stem cell research is also expected to increase with this amendment from the US government.

Key Geographies are Attracting Investments by Promoting Stem Cell Tourism
Countries that are advanced in providing stem cell therapies are taking advantage to attract investments from other countries by promoting stem cell tourism. The lack of stem cell therapy in a country forces the citizens suffering from debilitating conditions to travel to other countries where stem cell treatment is available. There has been an increase in the number of patients traveling from developed nations to countries like China, Thailand, Germany, Dominican Republic, Costa Rica, Israel and Argentina. Most of these countries promote stem cell tourism. This has the potential for excellent revenue generation for these countries.

The role of stem cell research as an integral part of therapeutics, as well as its commercial potential is now being recognized by most major countries of the world. Stem cell based therapies have immense market potential, driven by a strong pipeline that caters to high unmet needs. Stem cell research is now firmly on the path to being developed and commercialized fully. Currently, the technology is in its early stages of development, which implies that barriers to entry in this market are relatively low. Meeting the vast unmet need that stem cell research will eventually target, along with a strong pipeline of therapeutic candidates, suggests that it is a fast growing market that will offer attractive opportunities for investment in the near future.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=130308&rt=Stem-Cell-Research-Market-Trends-Investment-Trends-and-Pipeline-Analysis.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

India Offshore Non-voice Insurance BPO industry

Bharatbook added a new report on “India Offshore Non-voice Insurance BPO industry” analyses the global Insurance Industry and its ability to outsource along with the in-depth analysis of outsourcing potential and processes in Indian BPO market.

India Offshore Non-voice Insurance BPO industry report ( http://www.bharatbook.com/detail.asp?id=130291&rt=India-Offshore-Non-voice-Insurance-BPO-industry.html ) says that BPO is no longer an optional strategy but it is a strategic necessity. BPO and ITO continue to find favour with organisations looking to slash costs and raise productivity. Low labour costs, a huge pool of skilled manpower, and abundant natural resources make India a highly competitive manufacturing base for global exports in addition to catering to the vast domestic market. The use of English for business and official communication, and the high-quality managerial and technical talent created by some of the best higher education system in the developing world, add to India’s business friendliness.

SCOPE OF REPORT

The global business process outsourcing (BPO) industry ranks amongst the fastest-growing industries in the world. In the global BPO market, BFSI has emerged as the fastest-growing sector. Within the global BFSI BPO market, insurance segment accounts for more than 25% share. BPO is no longer an optional strategy but it is a strategic necessity. BPO industry has demonstrated its ability to reduce insurance back-office costs by 30% to 50%.

An understanding of the global insurance industry is necessary to comprehend the potential for insurance BPO services. This report contains a comprehensive overview of the global insurance industry with a special reference to the US, the UK and Australia.

The Industry report – Non- voice BPO in Insurance analyses the global Insurance Industry and its ability to outsource along with the in-depth analysis of outsourcing potential and processes in Indian BPO market. It presents the future outlook of one of the fastest growing industry worldwide.

KEY POINTS DISCUSSED
Non-voice offshore Insurance-BPO services industry in India
Insurance industries in the US, the UK, and Australia
The global outsourcing potential and the list of major outsourcing and willing to outsource insurance companies in US and UK
Operational structure of insurance company
Current & emerging Insurance process being outsourced
Contribution of BFSI segment in total BPO revenues in India as well as break-up of voice and non-voice BFSI
Outsourcing Potential – Why India?
Issues and challenges faced by the industry
An exclusive list of niche, captive and third party BPOs in India
Recent insurance outsourcing contracts signed by Indian BPO vendors
Profiles of Indian insurance BPO vendors and their respective functions – Company info, brief write –up, milestones, its competitors, revenues
Future outlook – Offshore Non-voice Insurance BPO industry in the year ahead.

REASONS WHY YOU SHOULD BUY THE REPORT
sharpen the focus and identify new markets
crystallizing strategic plans
learning about outsourcing trends in the insurance industry.
Gaining a comprehensive understanding of a fast-growing industry.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=130291&rt=India-Offshore-Non-voice-Insurance-BPO-industry.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

China shipbuilding market to grow steadily due to rise in international trade

Bharatbook added a new report on “Shipbuilding Industry in China 2010″ covering one of the largest industries in China with strong potential. This report is a part of Manufacturing Industry Series.
Shipbuilding Industry in China 2010 report ( http://www.bharatbook.com/detail.asp?id=130234&rt=Shipbuilding-Industry-in-China-2010.html ) covering an industry which has been globally competitive. China is the second largest player in the global shipbuilding industry, led by South Korea. Major government initiatives have been implemented towards cushioning the market from the recession. It has been estimated that China will be the market leader by 2015.

The report begins with an introduction to the global shipbuilding market which includes current and expected growth in installed capacity and the share of backlog for major countries in this space. An overview of China’s shipbuilding market has been provided including current and estimated figures for installed capacity, its global share in vessel production and existing segmentation in sales.

The characteristics of the market have been analyzed and include – growing trade levels, growth in LNG transport vessels, global economic downturn affecting demand, overcapacity in the shipping market and price of steel impacting the market. The major government programmes and investments towards the development of the industry have been discussed including the adjustment and revitalization plan of Chinese shipping industry, financial assistance to restructure the industry, tax relief and other initiatives.

Competition section profiles the major players in the market. The section contains a snapshot of the corporations’ financial performance and business highlights, providing an insight into the existing competitive scenario.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=130234&rt=Shipbuilding-Industry-in-China-2010.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

Future of the In-Vitro Diagnostics Market to 2016

Bharatbook.com added a new report on “The Future of the In-Vitro Diagnostics Market to 2016 – Increasing Diagnostic Procedures Drive Demand” gives Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
The Future of the In-Vitro Diagnostics Market to 2016 – Increasing Diagnostic Procedures Drive Demand report ( http://www.bharatbook.com/detail.asp?id=130193&rt=The-Future-of-the-In-Vitro-Diagnostics-Market-to-2016-Increasing-Diagnostic-Procedures-Drive-Demand.html ) provides key data, information and analysis on the global in-vitro diagnostics market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on seven in-vitro diagnostics market categories – Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture and Haematology. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

Scope

- Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Belgium, Netherlands, Japan, China, India, Australia, Taiwan, republic of Korea, Brazil, Argentina, Mexico, Israel and South Africa.
- Global Market size and company share data for seven In-Vitro Diagnostics market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture and haematology.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
- Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
- Competitive landscape and key company profiles. Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, Becton, Dickinson (BD), Bio-Rad Laboratories, Inverness Medical Innovations, Sysmex, Gen-Probe and Dade Behring.
- Key in-pipeline products and technologies expected to hit the global In-Vitro Diagnostics market in the near future.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the In-Vitro Diagnostics market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline. Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the In-Vitro Diagnostics market landscape? – Identify, understand and capitalize
- Make more informed business decisions from the insightful and in-depth analysis of the In-Vitro Diagnostics market and the factors shaping it.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=130193&rt=The-Future-of-the-In-Vitro-Diagnostics-Market-to-2016-Increasing-Diagnostic-Procedures-Drive-Demand.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook

Non-Traditional Players in Retail Banking – The Customer Opportunity

Bharatbook.com added a new report on “Non-Traditional Players in Retail Banking: The Customer Opportunity” Discusses the opportunities that exist in the market for non-traditional providers, and the threats to their prospects for success.
Non-Traditional Players in Retail Banking: The Customer Opportunity report ( http://www.bharatbook.com/detail.asp?id=130030&rt=Non-Traditional-Players-in-Retail-Banking-The-Customer-Opportunity.html ) assess that the financial crisis has had a huge impact upon the banking world. Many established banks have been weakened, subject to tougher regulation, and suffering from diminished trust. This has created an opening for non-traditional providers to move in and take advantage of their stronger reputations. However, they also need to be aware of obstacles, such as customer inertia, that stand in their way.

Scope

* Strengths that can provide non-traditional entrants with a competitive edge over established banks, such as expertise in customer analytics.
* Weaknesses that such providers need to deal with, such as high levels of customer inertia and the difficulties faced in selling advice-led products.
* Opportunities that will benefit these institutions, for example technological developments lowering the costs of entry.
* Threats that exist to the wellbeing of new, non-traditional providers, such as lack of expertise in the provision of financial services.

Highlights

Expertise in database management and customer analytics gives supermarkets and other retailers a competitive advantage over the banks when it comes to marketing products and services.

Non-traditional providers will find it extremely difficult to overcome the high degree of inertia in the current account market.

Not having launched operations in the immediate aftermath of the banking crisis means that prospective entrants may have missed their best window of opportunity to win over disaffected customers.

Reasons to Purchase

* Presents case studies of providers who have already entered, or are in the process of entering, the financial services industry.
* Highlights the main strengths that new entrants to retail banking can exploit, as well as the weaknesses they need to contend with.
* Discusses the opportunities that exist in the market for non-traditional providers, and the threats to their prospects for success.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=130030&rt=Non-Traditional-Players-in-Retail-Banking-The-Customer-Opportunity.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook